Affiliation:
1. Russian University of Medicine of the Ministry of Health of the Russian Federation
Abstract
The article assesses impact of the angiotensin converting enzyme inhibitors, angiotensin II receptor blockers and angiotensin receptor and neprilysin antagonists in the framework of combined cardial therapy on sSt2, NT-proBNP and Gal-3 levels in patients with stable ischemic heart disease and chronic heart failure of functional classes I–III, having suffered COVID-19 during 12 months of observation
Publisher
Joint Editorial Office of the Ministry of Internal Affairs of Russia